Since JQ1-sensitive cells express high levels of both OLIG2 and LGR5, we anticipate that BET inhibition specifically targets the proneural glioma stem cell niche and makes these cells even more susceptible to genotoxic effects of TMZ. This evidence concerns the gene OLIG2 and central nervous system cancer.